Focus-out Occhiali sull'emmetropizzazione nei bambini cinesi
Effetto degli occhiali di messa a fuoco periferica sull'emmetropizzazione nei bambini cinesi di età compresa tra 6 e 8 anni: studio clinico randomizzato di 2 anni.
The purpose of this study is to characterize the effects of peripheral focous-out glasses on emmetropization in non-myopic Chinese Children Aged 6-8 Years.This is a prospective, parallel-controlled randomized trial.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
Myopia is one of the most common eye diseases that cause visual impairment and blindness, and the high rate of myopia in young people is a major public health issue. Based on the clinical studies of optical defocusing to regulate eye growth and refractive changes through visual signal feedback, we hypothesize that early wearing of peripheral defocus glasses in children can slow down the process of emmetropization and even prevent the onset of myopia by producing more myopic defocusing. The aim of this study is to investigate whether wearing peripheral defocus glasses can effectively delay emmetropization in non-myopic children aged 6-8 years , and to further explore its effect on preventing the onset of myopia.
The study adopts a 2-year,single-centre, randomized, parallel-controlled trial with a non-blinded design. Subjects who pass the screening period will have their baseline data collected and will be assigned to the experimental or control groups according to the randomization principle. The experimental group will be fitted with Direct Emmetropia with Focus-out Glasses (hereafter referred to as DEFOG) to guide the emmetropization process. The control group will be given no treatment and will be a blank control. Baseline data including visual acuity, cycloplegic objective refraction, axis length, accommodation amplitude, strabismus examination, pupil size, choroidal thickness and peripheral retinal refraction will be measured when enrolled in the group and follow-up data will be measured at month 6, 12, 18 and 24. The primary interest of this study will be studied by comparing the difference in cycloplegic objective refraction changes between month 24 and baseline in the two groups of subjects.
Tipo di studio
Tipo di studio
Iscrizione (Effettivo)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, Cina, 201110
- Children's Hospital of Fudan University
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Age: ≥6 and ≤8 years at enrollment.
- At least one parent' s Spherical equivalent refraction≤-3.00D.
- Spherical equivalent refractions (SERs) under cycloplegia: +0.50 to +1.50 diopters (D)
- Astigmatism ≤1.00 D .
- Anisometropia ≤1.00 D.
- Best Corrected Visual Acuity (BCVA) : 1.0 or better
- Provision of consent written by subject's legal guardian
- Willing and able to participate in all required activities of the study
Exclusion Criteria:
- Any of the following abnormalities on the ocular surface, such as trachoma, pemphigoid, chemical injury, heat burn, radiation injury, etc.
- Eyelid abnormalities (e.g. entropion, ectropion, tumor, edema, blepharospasm, incomplete eyelid closure, severe trichiasis, severe ptosis) ,which affect eyelid function in either eye
- Eye diseases such as strabismus, amblyopia, anisometropia, fundus diseases, and accommodation abnormality,etc.
- Prior treatment of myopia control in either eye, including but not limited to drugs, orthokeratology, low-level red-light therapy, etc.
- Noncompliance with measurement at enrollment.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: DEFOG group
Subjescts will wear DEFOG glasses(peripheral focus-out glasses). |
Subjects in the intervention group will wear peripheral focus-out glasses ≧8 hours a day and ≧5 days a week. |
|
Nessun intervento: Control group
Subjects in the control group will just be observed. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Overall Changes of Cycloplegic Objective Refraction(spherical equivalent refraction, SER)(D)
Lasso di tempo: From baseline till the 24th month
|
Changes of cycloplegic objective refraction(i.e reflected by SER) from baseline till the 24th month (only the right-eye data included). Objective refraction data will be examined by AUTO REF/KERATOMETER. Ciliary muscle paralysis will be performed by using 1% cyclopentanone eye drops, 2 doses in each eye, 2 doses 5 minutes apart. The optometry will be performed after 20 minutes of complete ciliary muscle paralysis (disappearance of pupil response to light or pupil diameter at least greater than 6 mm). SER is calculated by adding the sum of the sphere power with half of the cylinder power. Baseline data will be measured at the time of enrollment. Follow-up data will be measured on the 24th month from baseline. The 24th month data will be subtracted from the baseline data to obtain changes. |
From baseline till the 24th month
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Changes of Cycloplegic Objective Refraction(SER) (D)
Lasso di tempo: The 6th month, the 12th month and the 18th month from baseline
|
Changes of cycloplegic objective refraction (i.e reflected by SER) different follow-up time and the baseline time (only the right-eye data included). Objective refraction data will be examined by AUTO REF/KERATOMETER. |
The 6th month, the 12th month and the 18th month from baseline
|
|
Myopia
Lasso di tempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Cycloplegic SER≦-0.50D at any follow-up time. Objective refraction data will be examined by AUTO REF/KERATOMETER. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Changes of Axial Length(AL)(mm)
Lasso di tempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Changes of Axial Length (AL) between different follow-up time and the baseline time (only the right-eye data included).AL will be examined by IOL Master. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Amplitude of Accommodation (AMP)(D)
Lasso di tempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Amplitude of Accommodation (AMP) at any follow-up time (only the right-eye data included). AMP will be examined by lens test. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Uncorrected Visual Acuity
Lasso di tempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
The Logarithmic Visual Acuity at any follow-up time (only the right-eye data included). |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Strabismus Examination(△)
Lasso di tempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Strabismus examination at any follow-up time by SYNOPTOPHORE. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Changes of Choroidal Thickness (ChT) (um)
Lasso di tempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Changes of Choroidal Thickness (ChT)between different follow-up time and the baseline time (only the right-eye data included). ChT will be examined by OPTICALCOHERENCETOMOGRAPHY. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Pupil size(mm)
Lasso di tempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Pupil size at any follow-up time (only the right-eye data included). |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Peripheral Retinal Refraction(D)
Lasso di tempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Peripheral Retinal Refraction at any follow-up time (only the right-eye data included). Peripheral Retinal Refraction will be examined by AUTO FUNDUS CAMERA. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
The percentage of participants with fast myopic shift
Lasso di tempo: From baseline till the 24th month
|
The percentage of participants with fast myopic shift over 2 years(only the right-eye data included). The fast myopic shift is defined as cycloplegic objective refraction (i.e reflected by SER) myopic shift of at least 1.00 D. Objective refraction data will be examined by AUTO REF/KERATOMETER. |
From baseline till the 24th month
|
|
Corneal curvature(D) or radius of curvature(mm)
Lasso di tempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Corneal curvature or radius of curvature(only the right-eye included). They can be interconverted. Data will be examined by AUTO REF/KERATOMETER. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Astigmatism (D)
Lasso di tempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
The adtigmatism at any follow-up time (only the right-eye data included). |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Collaboratori e investigatori
Sponsor
Sponsor
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Effettivo)
Completamento primario
Completamento dello studio (Effettivo)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- DEFOG
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .